More investment needed on Medical Research, says Kiran Mazumdar Shaw Ruchika Sharma1 Nov 2020 10:00 AM ISTMangaluru: Biocon Limited Chairperson Kiran Mazumdar Shaw on Wednesday stressed the urgent need for increasing investment on Medical Research in order...
Biocon among top 5 biotech employers globally Ruchika Sharma31 Oct 2020 3:22 PM ISTBengaluru: Pharma major, Biocon Ltd, has been ranked among the Top 5 Global Biotech Employers for 2020 on the prestigious U.S. based...
SEBI imposes fine on Biocon's regulatory affair officer for insider trading Ruchika Sharma26 Oct 2020 3:18 PM ISTMumbai: In a major setback to Biocon Ltd., markets regulator Securities and Exchange Board of India (SEBI)on Friday levied a fine on an employee...
Biocon net profit declines 23 percent at Rs 195 crore in Q2 Ruchika Sharma25 Oct 2020 9:45 AM ISTNew Delhi: Biotechnology major Biocon on Friday reported a 23.01 per cent fall in its consolidated net profit to Rs 195.4 crore for the second quarter...
Biocon employee penalized by SEBI for violating insider trading norms Ruchika Sharma26 Sept 2020 4:09 PM ISTBiocon Ltd's employee Girija Kelath violated the Prohibition of Insider Trading (PIT) Regulations by trading in the shares of Biocon during the...
Biocon names Anupam Jindal as new Chief Financial Officer Ruchika Sharma24 Sept 2020 3:45 PM ISTBengaluru: Drug major Biocon Limited has recently announced that Anupam Jindal has been appointed as the company's new Chief Financial Officer (CFO)....
Biocon, APSSDC ink MoU to set up skill colleges across Andhra Pradesh Ruchika Sharma20 Sept 2020 12:00 PM ISTBiocon will also help APSSDC in designing the curriculum, training faculty, offering industrial training and visits, identifying the equipment...
Biocon Chairman Kiran Mazumdar Shaw tests positive for COVID-19 Farhat Nasim18 Aug 2020 5:11 PM ISTBengaluru: In an unfortunate incident, the Chairman of Bengaluru-based drugmaker Biocon- Kiran Mazumdar Shaw has been tested positive for fatal...
Tata Capital Growth Fund to invest Rs 225 crore in Biocon Biologics Ruchika Sharma1 Aug 2020 11:42 AM ISTPost the completion of this transaction, Biocon will hold 95.25 per cent stake in Biocon Biologics, the biotechnology major added.
Biocon to furnish more data for consideration of Itolizumab in treating COVID patients Farhat Nasim29 July 2020 4:24 PM ISTBengaluru: After facing rejection from the Health Ministry, Bengaluru-based drugmaker Biocon is now preparing to present 'more data' for consideration...
Setback to Biocon: Health Ministry Says NO To Psoriasis Drug Itolizumab In Clinical Management Protocols For COVID-19 Ruchika Sharma27 July 2020 3:59 PM ISTNew Delhi: In a major setback to drug major, Biocon, the National Task Force on COVID-19 has decided against including Itolizumab drug in clinical...
Biocon net profit falls 26 percent to Rs 167.8 crore in Q1 Medical Dialogues Bureau26 July 2020 9:45 AM ISTBengaluru: Biotechnology major Biocon has reported a 26.30 percent decline in its consolidated net profit at Rs 167.8 crore for the quarter ended June...
